Tavasoli Ali Reza, Rostami Parastoo, Ashrafi Mahmoud Reza, Karimzadeh Parvaneh
Pediatric Neurology Division, Neurometabolic Registry Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Division of Endocrinology and Metabolism, Department of Pediatrics, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Iran J Child Neurol. 2017 Spring;11(2):57-60.
Ethylmalonic encephalopathy (EE) is a severe mitochondrial disease of early infancy clinically characterized by a combination of developmental delay, progressive pyramidal signs, and vascular lesions including petechial purpura, orthostatic acrocyanosis, and chronic hemorrhagic diarrhea. Biochemical hallmarks of the disease are persistently high level of lactate, and C4-C5-acylcarnitines in blood, markedly elevated urinary excretion of methylsuccinic and ethylmalonic (EMA) acids. Here we report two patients with EE as a 16-months-old male infant and a 2-yr-old boy referred to Pediatric Neurology Clinic in Children's Medical Center, Tehran-Iran that in one patient genetic analysis revealed a homozygous mutation of the ETHE1 gene in favor of ethylmalonic acidemia.
乙基丙二酸脑病(EE)是一种严重的婴儿早期线粒体疾病,临床特征为发育迟缓、进行性锥体束征和血管病变,包括瘀点性紫癜、直立性手足发绀和慢性出血性腹泻。该疾病的生化特征是血液中乳酸和C4 - C5酰基肉碱水平持续升高,甲基琥珀酸和乙基丙二酸(EMA)酸的尿排泄量显著增加。在此,我们报告两名EE患者,一名16个月大的男婴和一名2岁男孩,他们被转诊至伊朗德黑兰儿童医学中心的儿科神经科诊所,其中一名患者的基因分析显示ETHE1基因纯合突变,支持乙基丙二酸血症的诊断。